AI주식인사이트AI Stock Insight
B

종근당홀딩스

001630KOSPI

61.9 / 100

Reference Date: 2026-09-08

Financial Score32.5 / 40
News Sentiment18.4 / 25
Momentum4.0 / 20
Disclosure7.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue metrics are weak. Slightly down 2.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

JonggeunDang Holdings became a holding company through a corporate split in 2013, owning key subsidiaries such as JonggeunDang, Kyungbo Pharmaceuticals, and JonggeunDang Bio. Its primary revenue streams include management fees, brand usage fees, and dividends, with a strategy focused on specialized business areas to enhance corporate and shareholder value. Major subsidiaries operate in diverse sectors like raw pharmaceutical materials, finished drugs, and health functional foods.

Number of Employees

38people

Average Salary

143.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
4.57Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR
0.21Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
6.16Industry Average 8.002.5Point

Below industry avg

Debt Ratio
10.95Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20257.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲4.5% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲86.5% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 5.3% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 73.8

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 38,850Won52-week high 53,70052-week low 36,700
1-month return2.0Point

1m -2.88% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 2Negative 1
  • Negative[기재정정]주요사항보고서(영업정지)(자회사의 주요경영사항)2026-08-31
  • Neutral투자판단관련주요경영사항(자회사의 주요경영사항)2026-08-14
  • Neutral반기보고서 (2026.06)2026-08-14